NeoGenomics, Inc. Common Stock (NEO) Stock
Fundamentals
Source: third-party data provider, as of October 12, 2026
Compare with NEO
Recent news

Stryker, Neogenomics Announce CEO Transitions; But One Stock Dives
Stryker, Neogenomics Announce CEO Transitions; But One Stock Dives
NEO

NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan
NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan
NEO

NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference
NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference
NEO

NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
NEO
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 40.46
- MACD 12/26/9
- -0.26
- EMA 9 of MACD
- 0.17
- MACD histogram
- -0.43
- SMA 50
- $17.45
- Price below SMA 50
- EMA 50
- $17.10
- Price below EMA 50
- SMA 200
- $12.45
- Price above SMA 200
- EMA 200
- $13.46
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 9, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 3 analysts
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Stryker, Neogenomics Announce CEO Transitions; But One Stock Dives
Stryker, Neogenomics Announce CEO Transitions; But One Stock Dives
NEO

NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan
NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan
NEO

NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference
NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference
NEO

NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
NEO

Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today?
Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today?
NEO

NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring
NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring
NEO

Neo Performance Materials Q2 Earnings Call Highlights
Neo Performance Materials Q2 Earnings Call Highlights
NEO

NeoGenomics, Inc. (NEO) Hit a 52 Week High, Can the Run Continue?
NeoGenomics, Inc. (NEO) Hit a 52 Week High, Can the Run Continue?
NEO

NeoGenomics Q2 Earnings Call Highlights
NeoGenomics Q2 Earnings Call Highlights
NEO

NeoGenomics Reports Second Quarter 2026 Results
NeoGenomics Reports Second Quarter 2026 Results
NEO
News tone: automated (AI) classification of the article's content, not a price prediction.
About NeoGenomics, Inc. Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Anthony P. Zook | CEO & Director | 1961 |
| Mr. Warren Stone | President & COO | 1973 |
| Ms. Elizabeth A. Floegel | Chief Digital & Information Officer | 1976 |
| Mr. Abhishek Jain | Executive VP & CFO | 1976 |
| Mr. Gregory D. Aunan | Senior VP & Chief Accounting Officer | 1969 |
| Mr. Andrew Frederick Brackmann C.F.A. | Vice President of Investor Relations | — |
| Mr. Clarence Cooper Esq. | Vice President of Compliance & Privacy | — |
| Dr. Andrew A. Lukowiak Ph.D. | Chief Innovation Officer | 1972 |
| Priya Vedaraman | Senior Vice President of Finance | — |
| Ms. Kristi McKeown | Chief Commercial Officer | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 12, 2026
Technical indicators
- RSI 14
- 40.46
- MACD 12/26/9
- -0.26
- EMA 9 of MACD
- 0.17
- MACD histogram
- -0.43
- SMA 50
- $17.45
- Price below SMA 50
- EMA 50
- $17.10
- Price below EMA 50
- SMA 200
- $12.45
- Price above SMA 200
- EMA 200
- $13.46
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 9, 2026. Technical data, not a recommendation.
Analyst views
3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $20.00
- Average
- $23.33
- High
- $28.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +9.5 | -27.2 | +4.1 | |||||||||
| 2022 | -36.1 | -7.3 | -42.3 | -23.7 | -13.6 | +1.2 | +20.9 | -0.8 | -14.5 | -12.6 | +46.5 | -17.3 |
| 2023 | +30.7 | +34.8 | +5.0 | -13.4 | +16.7 | -9.0 | +9.8 | -14.3 | -18.9 | +17.8 | +32.0 | -14.8 |
| 2024 | -6.9 | +5.4 | -1.6 | -9.6 | -1.8 | +2.6 | +27.3 | -5.6 | -7.1 | -1.6 | +26.6 | -8.4 |
| 2025 | -13.3 | -28.0 | -0.9 | -31.6 | +0.3 | +2.0 | -34.7 | +70.2 | -12.4 | +12.0 | +23.7 | -2.2 |
| 2026 | +2.6 | -20.1 | -21.9 | +19.5 | +11.4 | +39.8 | +2.1 | +13.1 | +5.2 | -8.0 |



